Two-year $300 Million Special Diabetes Program Extended

In an overwhelming vote, the U.S. Senate approved a two-year extension of the Special Diabetes Program (SDP)—an initiative that accounts for roughly one-third of all federally-funded type 1 diabetes (T1D) research in the United States. “JDRF staff and our network of advocacy leaders and passionate volunteers all across the U.S. work tirelessly every day to […]

Your design can supercharge T1D research

Kids, start your sketching! Children living with type 1 diabetes (T1D), ages 5 to 18, are encouraged to let their imaginations race for the checkered flag in the 2015 Race Car Design Contest for JDRF, hosted by Motorcraft/Quick Lane Tire and Auto Centers. From now until March 12, children can submit their JDRF-inspired race car […]

DexCom CGM System to Offer Real-Time Glucose Data Sharing

DexCom CGM System to Offer Real-Time Glucose Data Sharing

DexCom G4® Platinum Continuous Glucose Monitoring System with Share Allows Users to Wirelessly Transmit Blood-Glucose Data and Alerts to Up to Five “Followers” in Real-Time    Medical device manufacturer DexCom is rolling out the first FDA-approved continuous glucose monitoring (CGM) system that allows real-time sharing of blood-glucose data. The DexCom G4® Platinum Glucose Monitoring System with […]

Meet Kimberly Roosevelt: JDRF 2015 Children’s Congress Chair

It is JDRF Advocacy’s great honor to announce that Kimberly C. Roosevelt, of Dallas, Texas, will serve as chair of JDRF 2015 Children’s Congress to be held in Washington, D.C., this July. Kim, a prominent JDRF Advocate and volunteer leader, and mother to 13-year-old Elizabeth who lives with type 1 diabetes (T1D), will welcome more […]

Investigating the Role of Regulatory T Cells in T1D

A video explains a potential new immune therapy in the words of the T1D investigator and one of the clinical study participants JDRF Research in the Field spoke to the lead investigator, Dr. Stephen Gitelman at the University of California San Francisco’s Children’s Hospital, who enrolled 14 people recently diagnosed with Type 1 Diabetes (T1D) […]

Next-Generation Artificial Pancreas System Launches

Medtronic’s New MiniMed®640G Artificial Pancreas System Predicts and Helps Prevent Deadly Low Glucose Emergencies A four year-old Australian boy with type 1 diabetes (T1D) is the first person to use a groundbreaking commercial artificial pancreas system that can predict and automatically prevent low blood-glucose emergencies. Medtronic’s MiniMed® 640G is an insulin pump/continuous glucose monitor combination […]

T1D Trial Looks to Teach an Old Drug New Tricks

JDRF-funded clinical study of a drug called TUDCA looks to improve beta cell functioning in people recently diagnosed with T1D Until recently, much of type 1 diabetes (T1D) research has focused on suppressing the autoimmune system to prevent or reverse disease, but this approach has been slow to yield promising, long-term results in people with […]

Re-educating the Immune System in T1D

Re-educating the Immune System in T1D

JDRF partner Selecta developed a novel technology for creating a T1D vaccine to potentially halt the disease process It has been more than 30 years since scientists identified the basic autoimmune feature of type 1 diabetes (T1D) when they discovered autoantibodies binding to targets from cells in the pancreas. And yet, devising therapies to halt […]